ahlam1399
01-11-2017, 07:32 PM
BRIEF-Merck KGaA, Darmstadt, Germany licenses four oncology research and development programs from Vertex
* Merck KGaA, Darmstadt, Germany, licenses four oncologyresearch and development programs from Vertex and becomes aleader in DNA damage and repairhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=8gitBakb-r4:XlQZ8au3P3A:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=8gitBakb-r4:XlQZ8au3P3A:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/8gitBakb-r4
* Merck KGaA, Darmstadt, Germany, licenses four oncologyresearch and development programs from Vertex and becomes aleader in DNA damage and repairhttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=8gitBakb-r4:XlQZ8au3P3A:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=8gitBakb-r4:XlQZ8au3P3A:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=8gitBakb-r4:XlQZ8au3P3A:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/8gitBakb-r4